Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulants
NCT06241677Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Apr 2024
- Primary completion
- Dec 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Open-label trial of tissue-plasminogen activator and tenecteplase in ischemic stroke (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Presence of symptomatic intracerebral hemorrhage at 1 year and Modified Rankin Scale at 3 months. Started Apr 2024; status: recruiting.
02
Drugs
tissue-plasminogen activatortenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06241677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06241677.